These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 33839200)
1. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200 [TBL] [Abstract][Full Text] [Related]
2. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation? Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832 [TBL] [Abstract][Full Text] [Related]
3. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report. Leclerc S; Royal V; Lamarche C; Laurin LP Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687 [TBL] [Abstract][Full Text] [Related]
4. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review. Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187 [TBL] [Abstract][Full Text] [Related]
5. Minimal change disease following the Moderna COVID-19 vaccine: first case report. Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669 [TBL] [Abstract][Full Text] [Related]
6. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review. Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881 [TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases. Hartley JL; Bailey N; Sharma A; Shawki H BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429 [TBL] [Abstract][Full Text] [Related]
8. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor. Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345 [TBL] [Abstract][Full Text] [Related]
9. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review. Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983 [TBL] [Abstract][Full Text] [Related]
10. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination. Pirzadeh A; Emami S; Zuckerman JE; Nobakht N Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318 [TBL] [Abstract][Full Text] [Related]
11. Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine. Hanna J; Ingram A; Shao T Can J Kidney Health Dis; 2021; 8():20543581211058271. PubMed ID: 34804557 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
14. Reactivation of minimal change disease after Pfizer vaccine against COVID-19. Marampudi S; Beshai R; Banker G J Osteopath Med; 2022 Oct; 122(10):499-501. PubMed ID: 35700437 [TBL] [Abstract][Full Text] [Related]
15. A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose. Mochizuki RI; Takahashi N; Ikenouchi K; Shoda W; Kuyama T; Takahashi D CEN Case Rep; 2022 Nov; 11(4):477-481. PubMed ID: 35435622 [TBL] [Abstract][Full Text] [Related]
16. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases. Gupta RK; Bhargava R; Shaukat AA; Albert E; Leggat J BMC Nephrol; 2020 Aug; 21(1):326. PubMed ID: 32753052 [TBL] [Abstract][Full Text] [Related]
17. Clinical features of acute kidney injury in patients with nephrotic syndrome and minimal change disease: a retrospective, cross-sectional study. Lin SP; Zhu FG; Meng JL; Sun XW; Cui J; Liang S; Yin Z; Sun XF; Cai GY Chin Med J (Engl); 2020 Nov; 134(2):206-211. PubMed ID: 33443939 [TBL] [Abstract][Full Text] [Related]
18. De novo Minimal Change Disease in an Adolescent after Pfizer-BioNTech COVID-19 Vaccination: A Case Report. Pella E; Sarafidis PA; Alexandrou ME; Stangou M; Nikolaidou C; Kosmidis D; Papagianni A Case Rep Nephrol Dial; 2022; 12(1):44-49. PubMed ID: 35611026 [TBL] [Abstract][Full Text] [Related]
19. Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection. De Fabritiis M; Angelini ML; Fabbrizio B; Cenacchi G; Americo C; Cristino S; Lifrieri MF; Cappuccilli M; Spazzoli A; Zambianchi L; Mosconi G Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451509 [TBL] [Abstract][Full Text] [Related]